DNA & Synthetic Conjugate Vaccines Travel & Edible Vaccines


Conjugate antibodies, made up of a bacterial polysaccharide antigen cross-connected to a bacterial protein, are among the best immunizations accessible today to avert bacterial diseases, for example, pneumococcal and meningococcal contaminations. Conjugate antibodies against bacterial pathogens with a substantial number of serotypes, for example, Streptococcus pneumoniae, generally cover just a few the current strains. Another recombinant DNA-based assembling innovation has been created to avert genuine bacterial diseases. This innovation can possibly prompt antibodies against unmanageable pathogens, for example, S. aureus and Shigella species and to rearrange and enhance the proficiency of creating complex conjugate antibodies.



 


  • Adjuvant
  • DNA vaccination
  • Prime-boost Vaccination
  • Reverse Vaccinology
  • DNA Immunization
  • Pneumococcal Conjugate Vaccine

Related Conference of DNA & Synthetic Conjugate Vaccines Travel & Edible Vaccines

November 28-29, 2024

38th International Conference on Immunology

Aix-en-Provence, France
December 12-13, 2024

5th International Conference on Immunology And Immunotherapy

Zurich, Switzerland
June 16-17, 2025

19th International Conference on European Immunology

Frankfurt, Germany

DNA & Synthetic Conjugate Vaccines Travel & Edible Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in